Lord Hunt of Kings Heath
Main Page: Lord Hunt of Kings Heath (Labour - Life peer)(1 year, 5 months ago)
Lords ChamberMy noble friend raises a very important point. We welcome the approval and introduction of crizanlizumab to help treat sickle cell patients, and we hope that this promising advance will have a major impact on the reduction of painful episodes and improve the quality of life for patients suffering from sickle cell disorders. Although this is a positive step, it is vital that people living with sickle cell disorders continue to get regular blood transfusions and red cell exchanges. This does not change the increasing need to have patients with ethnically matched blood, so my noble friend raises a good point.
She asked what we are doing. There is a range of techniques to increase awareness of the need to donate. NHSBT continues to invest and to prioritise the diversification of its donor base, and increasing the supply of Ro Kell-negative blood is one of its priorities. It is being supported through increased investment in marketing and the engagement of donors of black Caribbean and black African ethnicity, who are more likely to have this blood type.
My Lords, I understand that the authority has a community grants programme designed to encourage more donations from black and minority-ethnic people. Can the Minister say a little more about how successful that has been and whether the Government intend to put more resources into it in future?
The number of regular donors of black heritage reached an all-time high of almost 20,000 in the year to April 2023. In addition, 7,427 people of black heritage gave blood for the first time between April 2022 and 2023. This year, the NHS needs 12,000 new black heritage donors, and we are working to that. The latest plan launched in National Blood Week focused on black heritage recruitment. We are making extremely good progress in England, but there is still a lot to do.